Pedi Poll

 

Q. Should Bedaquilline {the new drug for treatment of XDR-TB} be made available in private sector_?

Poll Results
   
The immunity has still not developed after the first dose and so they are still vulnerable
 65.00%
   
They may have already been infected and in the incubation period while they got the vaccine
 35.00%
Remarks :
A
Abdul Latif
no. it will induce resistant organisms
9 years ago
C
Christian Beke
I think for a drug that treats multiresistant strains its use should be well controlled
9 years ago

View More Remarks


Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0